drugset / Trial / NCT04854993
Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted Prostatectomy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this prospecive randomized study is to evaluate the effects of a dose of sugammadex increased by 50% compared to a standard dose on recovery time from deep neuromuscular block in elderly patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP). Secondary objectives are to evaluate the different extubation time, time to exit from the operating room (OR), lenght of stay in post-anaesthesia care unit (PACU) and safety (hemodynamic parameters and respiratory function).
Timeline
- Start
- 2021-07-13
- Primary completion
- 2022-09-20
- Completion
- 2022-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sugammadex | Other / unclassified | 4 mg/kg | Intravenous |
| Subject | Sugammadex | Other / unclassified | 6 mg/kg | Intravenous |